You are here

Home

Morgan and Mendel Genomics, Inc.

Company Information
Address
1120 Morris Park Ave Ste 3A
Bronx, NY 10461-1463
United States


https://www.morganandmendel.com
Information

UEI: JHNHD3R1TCT8

# of Employees: 3
Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No

Award Charts




Award Listing

  • Record 1 TO 6

  1. Precision genomics for United States Air Force personnel using Cancer Risk B and Cancer Risk C

    Amount: $49,955.00

    Morgan and Mendel Genomics (MMG) is a functional genomics company developing cutting edge science to identify genetic disruptions in human cells with high sensitivity and specificity, low cost, and ra ...

    SBIRPhase I2022Department of Defense Air Force

  2. Robust Predictor of Colon Cancer Risk

    Amount: $968,518.00

    Summary At least 500,000 people in the United States have Lynch syndrome (LS), based on inheritance of a genetic pathogenic variant in the mismatch repair (MMR) pathway, placing them at high-risk for ...

    STTRPhase II2022Department of Health and Human Services National Institutes of Health

  3. Novel, rapid and accurate blood tests for detecting hereditary cancer risk

    Amount: $694,922.00

    10% of cancers are associated with an inherited pathogenic variant that can partially be identified by cancer gene panel testing, but up to 40% of cases show variants of uncertain significance (VUS) o ...

    SBIRPhase II2022Department of Defense Air Force

  4. Robust Predictor of Breast Cancer Risk

    Amount: $2,160,000.00

    SUMMARY Approximately 1.5 million women in the United States are at high-risk for developing breast cancer, based on inheritance of a germline mutation in a gene in the double strand-break (DSB) repai ...

    STTRPhase II2020Department of Health and Human Services National Institutes of Health

  5. Robust Predictor of Colon Cancer Risk

    Amount: $300,000.00

    Summary At leastpeople in the United States are at high risk for Lynch syndromebased on inheritance of a genetic mutation in the mismatch repairMMRor double strand breakDSBrepair pathwayMore than half ...

    STTRPhase I2018Department of Health and Human Services National Institutes of Health

  6. Robust Predictor of Breast Cancer Risk

    Amount: $302,000.00

    Summary Approximatelymillion women in the United States are at high risk for developing breast cancerbased on inheritance of a germline mutation in a gene in the double strand breakDSBrepair and cycli ...

    STTRPhase I2017Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government